Medical Policy Updates

Medical Laboratory Policy Update for November 12, 2019

Medical Guidelines Reason for Update
BRAF Genetic Testing In Patients With Melanoma AHS - M2029 Wording in the Policy, When Covered, and/or Not Covered section(s) changed from Medical Necessity to Reimbursement language, where needed.
Detection of Circulating Tumor Cells and Cell Free DNA in Cancer Management AHS - G2054 Deleted coding table from Billing/Coding section.  Wording in the Policy, When Covered, and/or Not Covered section(s) changed from Medical Necessity to Reimbursement language, where needed.  Minor reformatting of policy statements; no change to policy statement intent. 
Gene Expression Profiling for Uveal Melanoma AHS - M2071 Statement added to the When Not Covered section that testing is investigational in all other situations.
General Genetic Testing, Germline Disorders AHS - M2145 Wording in the Policy, When Covered, and/or Not Covered section(s) changed from Medical Necessity to Reimbursement language, where needed
General Genetic Testing, Somatic Disorders AHS - M2146 Wording in the Policy, When Covered, and/or Not Covered section(s) changed from Medical Necessity to Reimbursement language, where needed.
Molecular Panel Testing of Cancers to Identify Targeted Therapy AHS - M2109 Wording in the Policy, When Covered, and/or Not Covered section(s) changed from Medical Necessity to Reimbursement language, where needed.
Mutation Analysis in Myeloproliferative Neoplasms AHS - M2101 Wording in the Policy, When Covered, and/or Not Covered section(s) changed from MedicalNecessity to Reimbursement language, where needed